Abstract
Building on a large body of existing blood vascular research, advances in lymphatic research have helped kindle broader investigations into vascular diversity and endothelial plasticity. While the endothelium of blood and lymphatic vessels can be distinguished by a variety of molecular markers, the endothelia of uniquely diverse vascular beds can possess distinctly heterogeneous or hybrid expression patterns. These expression patterns can then provide further insight on the development of these vessels and how they perform their specialized function. In this review we examine five highly specialized hybrid vessel beds that adopt partial lymphatic programing for their specialized vascular functions: the high endothelial venules of secondary lymphoid organs, the liver sinusoid, the Schlemm’s canal of the eye, the renal ascending vasa recta, and the remodeled placental spiral artery. We summarize the morphology and endothelial expression pattern of these vessels, compare them to each other, and interrogate their specialized functions within the broader blood and lymphatic vascular systems.
Introduction
The discovery of new lymphatic markers has been a boon for lymphatic research helping to improve our understanding of the development and maintenance of lymphatics, as well as the identification of new lymphatic vessels. Historically, the distinction between blood and lymphatic vessels has been both categorical and demarcated. However, with new discoveries, we find that endothelial identity is more malleable and impressionable than previously thought. The combined expression of endothelial markers, lymphatic or otherwise, is often indicative of a specific set of functions conferred by the endothelium which possesses these markers (Potente and Makinen, 2017). For example, marker expression on lymphatic capillaries, blunt-ended vessels specialized to support trans-endothelial fluid and cellular transport, differs from that of collecting vessels, which are specialized to support intraluminal transport. The marker expression of these vessels further differ from valves, designed to block or allow intraluminal passage based on pressure gradients, and lymph node lymphatics which are more specialized for the presentation of antigens. Furthermore, the endothelia of these different lymphatic structures are influenced by signals from the local micro- and macro-environment, including from immune cells, extracellular matrix, and organ-specific cells and structures, which is most starkly exemplified by the changes that occur during tumor-associated lymphatic remodeling (Lutter and Makinen, 2014; Petrova and Koh, 2018; Wong et al., 2018; Garnier et al., 2019).
With these discoveries, it has become clear that the endothelium is far more plastic than previously thought and that transitions between blood and lymphatic identities occur (Ma and Oliver, 2017; Azimi et al., 2019). As such, a growing number of endothelial lined vessels which do not fit neatly into a classical vessel type have been identified. Recently, three different vessels, termed hybrid vessels, have been found to possess a combination of blood and lymphatics markers, presumably necessary for their highly specialized function: the Schlemm’s canal (SC) of the eye, the ascending vasa recta (AVR) of the renal medulla, and the remodeled spiral arteries (rSA) of the placental decidua (Aspelund et al., 2014; Park et al., 2014; Truong et al., 2014; Kenig-Kozlovsky et al., 2018; Pawlak et al., 2019). These vessels are in addition to an existing small catalog of highly specialized non-lymphatic vessels with similarly distinct expression patterns, including the liver sinusoid and high endothelial venules (HEV) of secondary lymphoid organs. In this review we compare and contrast the unique functions and expressional programing of these vessels to each other and to the classical features of blood and lymphatic vasculature and discuss the implications of these hybrid vessels within the greater context of physiology and endothelial biology.
Blood Vasculature
There are three fundamental blood vessel categories within the body: arteries carry blood away from the heart, capillaries exchange gasses and nutrients with local tissue, and veins transport blood back to the heart. Additionally, collateral vessels can shunt blood between vascular beds. Blood vessels are composed of three distinct layers (Mazurek et al., 2017). The tunica intima is the inner most layer with a single layer of endothelial cells (EC), basement membrane, and connective tissue. The endothelium and basement membrane in this layer can morphologically vary to allow for more or less permeability; continuous endothelia and basement membranes are less permeable than discontinuous ones with gaps allowing for passage of larger materials. The middle layer, called tunica media, is thicker in arteries than in veins and contains smooth muscle cells with connective and elastic tissue. The outer tunica adventitia layer, which is often thicker in veins than in arteries, anchors the vessel to the local tissue with elastic and connective fibers. The endothelium of capillaries instead have no smooth muscle, but sometimes have a discontinuous layer of pericytes. The permeability of capillaries vary based on location, but have universally small lumens which allows for gas and nutrient exchange between blood and local tissue.
A variety of versatile endothelial markers exist for the examination of the blood vasculature, including the tyrosine kinase receptors VEGFR1 and TIE2, the blood plasma and Weibel-Palade bodies-bound glycoprotein vWF, and the membrane glycoprotein PLVAP (Jaffe et al., 1973; Sato et al., 1995; Ferrara and Davis-Smyth, 1997; Yamamoto et al., 1998; Stan et al., 1999a, b). Additionally, the platelet endothelial adhesion molecule CD31, and the phosphoglycoprotein CD34, are often used as blood-specific endothelial markers, but can also be weakly expressed on lymphatic endothelium (van Mourik et al., 1985; Kriehuber et al., 2001; Podgrabinska et al., 2002). Distinct markers can differentiate between arterial and venous endothelium. In particular, the receptor tyrosine kinase EphB4 is a venous marker, while its cognate membrane-bound ligand ephrin B2 marks arterial endothelium, though both are expressed in blood capillaries (Wang et al., 1998). Additionally, the VEGFR2 co-receptors NRP1 and NRP2 are differentially expressed, the former is expressed on arterial endothelium and the latter on venous endothelium (Herzog et al., 2001). However, NRP2 is also a co-receptor of VEGFR3 on lymphatic endothelium, making it a more promiscuous venous marker (Yuan et al., 2002). Similarly, the mucin-like sialoglycoprotein, endomucin, preferentially expresses on both venous and lymphatic endothelia (Samulowitz et al., 2002). Pan-endothelial markers are widely used and valuable based on context and application. Commonly used pan-endothelial markers include the tyrosine kinase receptor VEGFR2, and the endothelial junctional protein, VE-Cadherin (Lampugnani et al., 1992; Shalaby et al., 1995; Dellinger et al., 2013; Hagerling et al., 2018).
Lymphatic Vasculature
Lymphatic vessels are responsible for maintaining fluid homeostasis, fat absorption, and immune cell trafficking. Excess interstitial fluid drains as lymph into blind-ended lymphatic capillaries that contain a permeable, discontinuous basement membrane and overlapping ECs that collectively function like unidirectional valves (Baluk et al., 2007). Lymph is then transported into lymphatic collectors, which have a structure similar to veins. Collectors have a basement membrane, lymphatic muscle cells, pericytes, and are regularly segmented by one-way endothelial valves (Oliver, 2004). Lymph can be pushed though the one-way valves by external pressures and phasic contractile forces generated by collector lymphatic muscle cells, effectively facilitating basal to apical flow (Muthuchamy et al., 2003). Collecting vessels can then move lymph through lymph nodes for antigen presentation to immune cells, and then drain back into the venous circulation (Randolph et al., 2017).
Formation of the mouse lymphatic vasculature begins around embryonic day 9.5 when a subpopulation of ECs on the cardinal vein express PROX1, a master regulator of lymphatic fate, which requires expression of the transcription factors SOX18 and COUP-TFII, the latter of which is considered a master regulator of venous fate (Wigle and Oliver, 1999; You et al., 2005; Francois et al., 2008). The PROX1+ cardinal vein ECs, which also express the membrane glycoprotein LYVE1, bud off the vein and acquire the expression of another membrane glycoprotein, podoplanin (PDPN) (Banerji et al., 1999; Breiteneder-Geleff et al., 1999). The ECs coordinately form a primitive lymph sac at embryonic day 11.5 in a process primarily mediated by VEGFR3/NRP2/VEGFC signaling (Karkkainen et al., 2004). Lymphangiogenesis from the lymph sac then forms the peripheral lymphatic network, supported by endothelial proliferation promoted by AM/CLR/RAMP2 signaling (Fritz-Six et al., 2008). Lymphatic valves are formed to help promote unidirectional flow toward the venous circulation, while a lymphovenous valve prevents blood from flowing into the lymphatics (El Zawahry et al., 1983). Notably, both types of valve LECs have distinct expression patterns from each other and more so from vessel wall LECs (Scallan et al., 2016; Janardhan and Trivedi, 2019).
Through derivation from the primitive lymph sac, most of the lymphatic vasculature derives from a venous origin (Srinivasan et al., 2007; Yang et al., 2012; Hagerling et al., 2013; Escobedo and Oliver, 2016). However, newer evidence in mice suggests that a subset of LECs are derived from non-venous sources in the heart (Klotz et al., 2015), dermis (Martinez-Corral et al., 2015), and mesentery (Mahadevan et al., 2014; Stanczuk et al., 2015), as well as LECs derived from the mesenchyme (Buttler et al., 2006; Wilting et al., 2006; Ulvmar and Makinen, 2016). Non-venous LECs were primarily identified by lineage tracing experiments with the venous/endothelial cell marker TIE2. Evidence suggests that LECs lacking TIE2 labeling in the heart and mesentery may instead derive from a hemogenic endothelium population, whereas the origin of non-venous dermal LECs currently remains unknown (Mahadevan et al., 2014; Klotz et al., 2015; Stanczuk et al., 2015).
High Endothelial Venules
The HEV are post-capillary swellings of venous blood vessels that are especially adapted for trafficking of lymphocytes. HEVs are found in secondary lymphoid organs, including lymph nodes and the Peyer’s patch of the small intestine, and are required for the function and organogenesis of these organs by recruiting essential lymphocyte populations. HEVs are covered by overlapping pericytes in a thick basement membrane, and HEV ECs are distinct from other blood ECs by their thick (or high) cuboidal shape, from which the vessel’s name derives (Figure 1A; Ager, 2017).
FIGURE 1
While the expression pattern of HEV ECs can have some variability by organ, HEV ECs have generally been found to express the lymphatic markers VEGFR3, LYVE1, and CCL21, but not PROX1 (Table 1; Gunn et al., 1998; Lacorre et al., 2004; Wrobel et al., 2005). LYVE1 functions as receptor for hyaluronan which is metabolized in the lymph node (Fraser and Laurent, 1989). CCL21, a ligand for CCR7, functions as a chemoattractant for immune cells (Yoshida et al., 1998). VEGFR3 expression on HEVs is controversial, but an abundance of evidence supports that it is expressed in many studies (Lacorre et al., 2004; Farnsworth et al., 2011). HEV ECs also express endothelial markers CD31, CD34, VE-Cadherin, and VEGFR2, and the blood endothelial markers vWF, PLVAP, and VEGFR1 (Pfeiffer et al., 2008; Farnsworth et al., 2011). As found on other venules, HEVs also express the membrane-bound glycoprotein endomucin, where it likely functions as a regulator of cellular adhesion (Samulowitz et al., 2002). Interestingly, HEV ECs do not express PDPN, but fibroblastic reticular cells that surround the HEV do and that expression is required to maintain VE-Cadherin expression and barrier function of HEV ECs (Farr et al., 1992; Herzog et al., 2013).
TABLE 1
Expression pattern of hybrid vessels.
L = Lymphatic; A = Arterial; V = Venous; |L| |V| |A| = Transiently expressed during development; l v a = Weakly expressed; (+) = Expressed; (−) = Not expressed; (±) = Transiently or Discontinuously Expressed; NRF = No Reporting Found; (±) = Reported both as expressed and not expressed. 1Hirashima et al. (2003) report that VEGFR2 is not expressed in the SA of the proximal decidua at embryonic day 12.5, but only after the endothelium has been replaced by fetal endovascular trophoblasts. Their data appears to show LacZ reporter staining for VEGFR2 in endothelial lined SAs, but this was not explicitly reported by the authors (Hirashima et al., 2003). This important distinction has not been made in some previous review articles (Rai and Cross, 2014). 2Staining done by Pupilli et al. (1997) shows low or absent vWF expression in ascending vasa recta, while the descending vasa recta shows clear expression, but the ascending vasa recta vWF staining was not explicitly reported by the authors. 3Yokomori et al. (2010) described PDPN as “scantly” expressed on LSECs. However, PDPN expression has been described on Kupffer cells which localized to the sinusoids which was not addressed in the study by Yokomori et al. (2010) and Hitchcock et al. (2015).
Liver Sinusoid
The liver sinusoid is a network of capillaries lined by a discontinuous endothelium. Liver sinusoidal ECs (LSECs) are flat and highly fenestrated (covering ∼20% of the surface), allowing for passage of plasma across the endothelium into the space of Disse located between the endothelium and adjacent hepatocytes (Figure 1B). The passage of plasma across LSECs is important for hepatic blood clearance of harmful compounds and drugs from the circulation. This clearance is supported by Kupffer cells within the sinusoid that phagocytose particles too large to pass through LSECs. LSECs have minimal basement membrane with a lack of an organized basal lamina and also lack tight junctions (Wisse, 1972).
LSECs have an interesting expression pattern that includes the lymphatic markers LYVE1, VEGFR3, and integrin α9, but not PROX1 (Table 1; Couvelard et al., 1998; Mouta Carreira et al., 2001). Similar to the lymph nodes, the liver metabolizes hyaluronan which its receptor, LYVE1, in LECS likely supports (Vrochides et al., 1996). PDPN has been described as “scantly” expressed on LSECs (Yokomori et al., 2010), but that study did not address if the signal came from PDPN-positive Kupffer cells within the sinusoid (Hitchcock et al., 2015). The pan-endothelial markers TIE2 and VEGFR2 are expressed on LSECs, however, the expression of some other pan-endothelial and blood markers in LSECs are unusually low (vWF, CD31) or absent (VE-Cadherin, CD34) (Lalor et al., 2006). Though it should be noted that the expressions of CD31 and VE-Cadherin are controversial since both have been reported to be either expressed or not expressed on LSECs (Lalor et al., 2006; Ding et al., 2010). The arterial and venous markers Ephrin B2 and EPHB4, respectively, are both expressed in LSECs, which is consistent with function of the liver sinusoid as a capillary plexus since Ephrin B2 and EPHB4 coordinately direct remodeling of capillary networks.
Schlemm’s Canal
The SC of the eye is a channel encircling the periphery of the cornea with a continuous EC monolayer on a discontinuous basement membrane which facilitates bloodless basal-to-apical flow similar to lymphatic capillaries (Figure 1C; Ramos et al., 2007; Aspelund et al., 2014). The SC functions as a regulator of intraocular pressure by providing passage for aqueous humor from the trabecular meshwork, draining then into the aqueous and episcleral veins (Tamm, 2009). The aqueous humor outflow is similar between mice and humans. However, only about 20% of total aqueous humor outflow passes through the SC in mice (Aihara et al., 2003), whereas a majority of outflow passes through the SC in humans. Historically, the SC was thought to be a blood vessel due to the expression of blood endothelial markers, including vWF (Dautriche et al., 2015), but more recently the rodent SC has been noted to possess many characteristics of lymphatic vessels.
In 2014, three groups independently identified the expression of PROX1, a transcription factor master regulator of lymphatic fate, in the mouse SC (Aspelund et al., 2014; Park et al., 2014; Truong et al., 2014), and has since been identified in the SC of rats (Jung et al., 2017). Interestingly, only a subset of lymphatic markers are expressed in the SC, including VEGFR3, CCL21, integrin α9, and low or transient expression of SOX18 and FOXC2. However, LYVE1 and PDPN expression is not detected in SC ECs. Meanwhile, the blood endothelial markers CD31, vWF, and endomucin are expressed in the SC, as wells as the pan-endothelial markers VE-Cadherin and TIE2, suggesting that these vessels acquire a blood/lymphatic hybrid identity (Table 1; Aspelund et al., 2014; Park et al., 2014; Truong et al., 2014). This hybrid identity is hypothesized to help the SC to perform its highly specialized function in a way that neither a classic blood nor lymphatic vessel could perform. Indeed, VEGFR3 signaling is required for SC development (Aspelund et al., 2014), and recent work shows that PROX1 is required for development and maintenance of the SC. Also the blood vessel marker VEGFR2 is required for development but gradually decreases expression from p4 to adulthood during a simultaneous increase in PROX1 and VEGFR3 expression. Interestingly, the lymphatic programing of the SC is flow-mediated; PROX1 and VEGFR3 expression is significantly decreased when aqueous humor outflow is decreased (Park et al., 2014). Since humans rely more on SC-mediated outflow than mice, these findings may have increased relevance to the pathophysiology of the human eye.
More recent work shows that TIE2 (Tek) signaling is required for both development and maintenance of the SC, and is otherwise necessary to perform its drainage function (Thomson et al., 2014; Kim et al., 2017). During development, TIE2 is an important regulator of vascular remodeling and stability. In the SC and lymphatics vessels, ANGPT1 and ANGPT2 function as agonists of TIE2, which differs from blood vessels where ANGPT2 acts as an antagonist to ANGPT1 activation of TIE2 (Augustin et al., 2009). Agonist signaling of TIE2 is required for SC development; mice lacking ANGPT1 and ANGPT2 or TIE2 develop glaucoma due to an unformed SC, restricting aqueous humor outflow. Furthermore, inducible deletion of Angpt1 and Angpt2 or Tek in adult mice demonstrate that agonist TIE2 signaling is also required to maintain SC integrity and PROX1 expression (Kim et al., 2017).
Ascending Vasa Recta
The AVR and descending vasa recta (DVR) of the renal inner medulla are blood vessels utilized for concentrating urine along the nephron (Pallone et al., 2003). The AVR in particular is highly fenestrated, lacks mural cell coverage, has a discontinuous basement membrane, and is important for fluid reabsorption back to the vasculature (Figure 1D; Schwartz et al., 1976; Takahashi-Iwanaga, 1991). These features are also attributed to lymphatic vessels which are otherwise absent or rare in the renal medulla (Russell et al., 2019). Similar to SC, the AVR expresses both PROX1 and VEGFR3, but not LYVE1 and PDPN. Additionally, the AVR expresses endomucin and blood endothelial markers CD31, CD34, VEGFR1, and PLVAP (Table 1; Kenig-Kozlovsky et al., 2018). Interestingly, despite typically being expressed in blood vessels, VEGFR2 expression was not found in the AVR (Kenig-Kozlovsky et al., 2018). VEGFR2 and VEGFR3 are able to hetero-dimerize and activate downstream signaling pathways, such as AKT signaling, that differ from those triggered by homo-dimerized VEGFR3, such as ERK signaling (Deng et al., 2015). Consequently, absence of VEGFR2 in these vessels could lead to increased VEGFR3 homo-dimer signaling (Dixelius et al., 2003). As postulated by Kenig-Kozlovsky et al. (2018) VEGFR3 may be implicated in vessel widening of the AVR, which is significantly wider than the DVR, as VEGFR3 responds to fluid shear stress by promoting outward vessel remodeling (Baeyens et al., 2015).
To date, the developmental origin of the AVR is not well understood. Further, it is unclear whether the AVR derives from a unique set of progenitor cells or undergoes differentiation while under development. It is likely that the acquisition of VEGFR3 is due in large part to PROX1 transcriptional activity (Hong et al., 2002; Petrova et al., 2002), but it is unclear what initiates PROX1 expression in the AVR. Examination of known promoters of PROX1 expression, such as SOX18 and KLF4, may help identify early regulatory mechanisms that push the AVR toward a hybrid identity.
The AVR also expresses TIE2 which is required for development of the AVR, but not the DVR (Kenig-Kozlovsky et al., 2018). Constitutive deletion of Tek or simultaneous deletion of Angpt1 and Angpt2 leads to early embryonic lethality (Dumont et al., 1994; Sato et al., 1995), but Kenig-Kozlovsky et al. (2018) overcame this lethal phenotype by inducing deletion of Tek or Angpt1 and Angpt2 simultaneously at embryonic day 16.5. These mice develop renal cysts and have reduced urine concentrating ability which is attributed to the absence of the AVR, despite the normal formation of the DVR (Kenig-Kozlovsky et al., 2018).
Spiral Arteries
The spiral arteries (SA) of the decidual placenta are tortuous maternal blood vessels that transport maternal blood to the fetal side of the placenta where gasses and nutrients are exchanged with the fetal vasculature. With the support of local uterine NK cells, SAs must remodel during midgestation to increase blood flow and nutrient delivery to support the growing fetus (Moll et al., 1978). In humans, poor SA remodeling is associated with pregnancy complications, including fetal growth restriction, preterm birth, and preeclampsia (Lyall, 2002; Pijnenborg et al., 2006), and can otherwise lead to long-term health complications for mother and child (Barker et al., 1989; Gastrich et al., 2010; Geelhoed and Jaddoe, 2010). Prior to remodeling, the SA is supported by smooth muscle coverage, extracellular matrix, and a basement membrane, but during SA remodeling smooth muscle coverage is shed, extracellular matrix degrades, and basement membrane is diminished (Figure 1E; Sweeney et al., 2006; Whitley and Cartwright, 2010; Robson et al., 2012). These changes help facilitate an increase in lumen diameter and reduced tortuosity to promote increased blood flow.
Our group recently discovered that rodent SAs acquire expression of a subset of lymphatic markers, similar to the SC and AVR (Pawlak et al., 2019). We found that the SA acquires these lymphatic markers during the remodeling period between embryonic day 11.5 to embryonic day 13.5 when smooth muscle coverage is shed and the lumen diameter expands. Similar to the SC and AVR, the remodeled SA (rSA) expresses PROX1 and VEGFR3, but not PDPN, as well as TIE2 and CD31 (Table 1; Goldman-Wohl et al., 2000). VEGFR3 expression in particular persists throughout pregnancy. Our work suggests that the rSA utilizes lymphatic expression to help expand the lumen diameter and modify the vascular tone to allow for increased blood flow, and that VEGFR3/VEGFC signaling in particular plays a central role in that function. The expression of VEGFR3 allows the SA to become responsive to locally secreted VEGFC which is required to promote remodeling. However, unlike the aforementioned hybrid vessels, the rSA expresses LYVE1, but only in a non-continuous subset of ECs. Also unlike the SC, the rSA does not express CCL21, which may be related to the immune privileged nature of the placenta intended to prevent an immunological maternal response to fetal antigens (Weber et al., 2013). Additionally, the rSA is not a fenestrated vessel and does not express endomucin, which is often associated with vessels that help perform fluid homeostasis.
Fundamentally, the differences in expression in the rSA compared to the other hybrid vessels likely relates to the physiological differences in function and origin of these vessels. The rSA regulates blood transport, the SC regulates aqueous humor fluid homeostasis, and the AVR serves as both a transport and homeostasis vessel. Though one key difference between rSAs and the other hybrid vessels and lymphatics is that rSAs are arterial while the others are of a venous origin (Srinivasan et al., 2007). It is important to note that some LECs are derived from a non-venous origin (Ulvmar and Makinen, 2016), and while VEGFR3 is regarded as a lymphatic marker in adult vessels, it is also expressed in fetal blood vessels, including arterioles. Furthermore, it should be appreciated that SAs acquire transient expression of the venous blood vessel marker EPHB4 prior to lymphatic expression, suggesting a shift from arterial to venous to lymphatic identity that may help facilitate the full transition and remodeling process (Zhang et al., 2008).
Closing Remarks
The molecular profile of hybrid vessels is related to the unique microenvironments in which they are located and the highly specialized functions they perform, and cell-autonomous mechanisms may also contribute to their heterogeneity. Notably, the molecular profiles of mature hybrid vessels appear to be plastic, as evident by expressional changes to HEVs in response to immunization (Liao and Ruddle, 2006). Indeed, this vessel plasticity under aberrant signaling is presumed to contribute to certain pathologies, such as poor spiral artery remodeling in preeclampsia and poor aqueous humor drainage via the SC in glaucoma (Karpinich and Caron, 2014; Pawlak et al., 2019).
It is worth commenting that some of the newly characterized hybrid vessels are found in regions that are either currently or historically believed to be devoid of lymphatic vessels (Dickinson and Gausas, 2006; Red-Horse et al., 2006; Castro et al., 2011; Lee et al., 2011). Certainly, the expansion of diverse and reliable lymphatic markers has enabled more precise characterization of these structures. It is also evident that the field is moving away from overreliance on only one or two lymphatic markers in in vivo studies, not only because expression patterns on vessels may be altered by local or organ-specific factors, but also because no single marker identified to date is completely exclusive to lymphatic vessels. Finally, instances of programmed and pathological endothelial mimicry could further complicate molecular profiling, particularly in a tumor environment.
It is likely that more uncharacterized hybrid vessels still remain to be identified. As with the aforementioned hybrid vessels, vascular beds with highly specialized functions may be ripe for the examination of lymphatic markers which may have been coopted to promote the specialized morphology that serves their function. Indeed, understanding how the lymphatic vasculature responds to pathological conditions may be informative in the identification and characterization of potential hybrid vessels (see the comprehensive review on this topic by Padera et al. (2016). Ultimately, what qualifies as a hybrid vessel may be debatable or evolve over time. Nevertheless, this can be considered a natural and positive outcome of our expanding appreciation for the breadth of endothelial plasticity and heterogeneity.
Statements
Author contributions
JP researched the literature and wrote the manuscript. KC provided direction on, reviewed, and edited the manuscript.
Funding
This was supported by the U.S. National Institutes of Health Grants R01 HD060860, HL129086, and DK119145 (KC), U.S. National Institutes of Health Ruth L. Kirschstein Institutional National Research Service Award T32 2T32HL069768-16 (JP trainee), and U.S. National Institutes of Health F31 Ruth L. Kirschstein Predoctoral Individual National Research Service Award HD095585 (JP).
Acknowledgments
We thank Dr. Wenjing Xu and Natalie R. Harris for helpful comments and assistance with manuscript preparation.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AgerA. (2017). High endothelial venules and other blood vessels. Critical regulators of lymphoid organ development and function.Front. Immunol.8:45. 10.3389/fimmu.2017.00045
2
AiharaM.LindseyJ. D.WeinrebR. N. (2003). Aqueous humor dynamics in mice.Invest Ophthalmol. Vis. Sci.445168–5173.
3
AspelundA.TammelaT.AntilaS.NurmiH.LeppanenV. M.ZarkadaG.et al (2014). The Schlemm’s canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.J. Clin. Invest.1243975–3986. 10.1172/JCI75395
4
AugustinH. G.KohG. Y.ThurstonG.AlitaloK. (2009). Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.Nat. Rev. Mol. Cell Biol.10165–177. 10.1038/nrm2639
5
AzimiM. S.MotherwellJ. M.HodgesN. A.RittenhouseG. R.MajbourD.PorvasnikS. L.et al (2019). Lymphatic-to-blood vessel transition in adult microvascular networks, A discovery made possible by a top-down approach to biomimetic model development.Microcirculation10.1111/micc.12595[Epub ahead of print].
6
BaeyensN.NicoliS.CoonB. G.RossT. D.Van den DriesK.HanJ.et al (2015). Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point.Elife4:e04645. 10.7554/eLife.04645
7
BalukP.FuxeJ.HashizumeH.RomanoT.LashnitsE.ButzS.et al (2007). Functionally specialized junctions between endothelial cells of lymphatic vessels.J. Exp. Med.2042349–2362. 10.1084/jem.20062596
8
BanerjiS.NiJ.WangS. X.ClasperS.SuJ.TammiR.et al (1999). LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.J. Cell Biol.144789–801. 10.1083/jcb.144.4.789
9
BarkerD. J.OsmondC.GoldingJ.KuhD.WadsworthM. E. (1989). Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.BMJ298564–567. 10.1136/bmj.298.6673.564
10
BazigouE.XieS.ChenC.WestonA.MiuraN.SorokinL.et al (2009). Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.Dev. Cell17175–186. 10.1016/j.devcel.2009.06.017
11
Breiteneder-GeleffS.SoleimanA.KowalskiH.HorvatR.AmannG.KriehuberE.et al (1999). Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries, podoplanin as a specific marker for lymphatic endothelium.Am. J. Pathol.154385–394. 10.1016/s0002-9440(10)65285-6
12
BullaR.VillaA.BossiF.CassettiA.RadilloO.SpessottoP.et al (2005). VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries.Exp. Cell Res.303101–113.
13
ButtlerK.KreysingA.von KaisenbergC. S.SchweigererL.GaleN.PapoutsiM.et al (2006). Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos.Dev. Dyn.2351554–1562. 10.1002/dvdy.20737
14
CastroE.Tony ParksW.GalambosC. (2011). Neither normal nor diseased placentas contain lymphatic vessels.Placenta32310–316. 10.1016/j.placenta.2011.01.013
15
CouvelardA.BringuierA. F.DaugeM. C.NejjariM.DaraiE.BeniflaJ. L.et al (1998). Expression of integrins during liver organogenesis in humans.Hepatology27839–847. 10.1002/hep.510270328
16
DagenaisS. L.HartsoughR. L.EricksonR. P.WitteM. H.ButlerM. G.GloverT. W. (2004). Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.Gen. Exp. Patterns.4611–619. 10.1016/j.modgep.2004.07.004
17
DasA.ShergillU.ThakurL.SinhaS.UrrutiaR.MukhopadhyayD.et al (2010). Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.Am. J. Physiol. Gastrointest. Liver Physiol.298G908–G915. 10.1152/ajpgi.00510.2009
18
DautricheC. N.TianY.XieY.SharfsteinS. T. (2015). A closer look at schlemm’s canal cell physiology.Implications for Biomimetics.J. Funct. Biomater.6963–985. 10.3390/jfb6030963
19
DellingerM. T.MeadowsS. M.WynneK.CleaverO.BrekkenR. A. (2013). Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature.PLoS One8:e74686. 10.1371/journal.pone.0074686
20
DengY.ZhangX.SimonsM. (2015). Molecular controls of lymphatic VEGFR3 signaling.Arterioscler. Thromb. Vasc. Biol.35421–429. 10.1161/ATVBAHA.114.304881
21
DickinsonA. J.GausasR. E. (2006). Orbital lymphatics, do they exist?Eye201145–1148. 10.1038/sj.eye.6702378
22
DieterichL. C.KleinS.MathelierA.Sliwa-PrimoracA.MaQ.HongY. K.et al (2015). DeepCAGE transcriptomics reveal an important role of the transcription factor MAFB in the lymphatic endothelium.Cell Rep.131493–1504. 10.1016/j.celrep.2015.10.002
23
DingB. S.NolanD. J.ButlerJ. M.JamesD.BabazadehA. O.RosenwaksZ.et al (2010). Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration.Nature468310–315. 10.1038/nature09493
24
DixeliusJ.MakinenT.WirzeniusM.KarkkainenM. J.WernstedtC.AlitaloK.et al (2003). Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.J. Biol. Chem.27840973–40979. 10.1074/jbc.m304499200
25
DumontD. J.GradwohlG.FongG. H.PuriM. C.GertsensteinM.AuerbachA.et al (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.Genes Dev.81897–1909. 10.1101/gad.8.16.1897
26
El ZawahryM. D.SayedN. M.El-AwadyH. M.Abdel-LatifA.El-GindyM. (1983). A study of the gross, microscopic and functional anatomy of the thoracic duct and the lympho-venous junction.Int. Surg.68135–138.
27
ElpekG. O. (2015). Neuropilins and liver.World J. Gastroenterol.217065–7073. 10.3748/wjg.v21.i23.7065
28
EscobedoN.OliverG. (2016). Lymphangiogenesis.Origin, specification, and cell fate determination.Annu. Rev. Cell Dev. Biol.32677–691.
29
FarnsworthR. H.KarnezisT.ShayanR.MatsumotoM.NowellC. J.AchenM. G.et al (2011). A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth.Cancer Res.716547–6557. 10.1158/0008-5472.CAN-11-0200
30
FarrA. G.BerryM. L.KimA.NelsonA. J.WelchM. P.AruffoA. (1992). Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues.J. Exp. Med.1761477–1482. 10.1084/jem.176.5.1477
31
FerraraN.Davis-SmythT. (1997). The biology of vascular endothelial growth factor.Endocr Rev.184–25.
32
FrancoisM.CapriniA.HoskingB.OrsenigoF.WilhelmD.BrowneC.et al (2008). Sox18 induces development of the lymphatic vasculature in mice.Nature456643–647. 10.1038/nature07391
33
FraserJ. R.LaurentT. C. (1989). Turnover and metabolism of hyaluronan.Ciba Found Symp.14341–53. discussion 5, 281–285.
34
Fritz-SixK. L.DunworthW. P.LiM.CaronK. M. (2008). Adrenomedullin signaling is necessary for murine lymphatic vascular development.J. Clin. Invest11840–50. 10.1172/jci33302
35
FujimotoT.InoueT.MakiK.Inoue-MochitaM.TaniharaH. (2016). Vascular endothelial growth factor-a increases the aqueous humor outflow facility.PLoS One11:e0161332. 10.1371/journal.pone.0161332
36
GarnierL.GkountidiA. O.HuguesS. (2019). Tumor-associated lymphatic vessel features and immunomodulatory functions.Front. Immunol.10:720. 10.3389/fimmu.2019.00720
37
GastrichM. D.FaroR.RosenT. (2010). Markers of preeclampsia and the relationship to cardiovascular disease, review of the twenty-first century literature.J. Matern. Fetal Neonatal Med.23751–769. 10.3109/14767058.2010.481316
38
GeelhoedJ. J.JaddoeV. W. (2010). Early influences on cardiovascular and renal development.Eur. J. Epidemiol.25677–692. 10.1007/s10654-010-9510-0
39
GermeyerA.HamiltonA. E.LaughlinL. S.LasleyB. L.BrennerR. M.GiudiceL. C.et al (2005). Cellular expression and hormonal regulation of neuropilin-1 and -2 messenger ribonucleic Acid in the human and rhesus macaque endometrium.J. Clin. Endocrinol. Metab.901783–1790. 10.1210/jc.2004-1769
40
Goldman-WohlD. S.ArielI.GreenfieldC.LavyY.YagelS. (2000). Tie-2 and angiopoietin-2 expression at the fetal-maternal interface, a receptor ligand model for vascular remodelling.Mol. Hum. Reprod.681–87. 10.1093/molehr/6.1.81
41
GrantA. J.GoddardS.Ahmed-ChoudhuryJ.ReynoldsG.JacksonD. G.BriskinM.et al (2002). Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.Am. J. Pathol.1601445–1455. 10.1016/s0002-9440(10)62570-9
42
GunnM. D.TangemannK.TamC.CysterJ. G.RosenS. D.WilliamsL. T. (1998). A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.Proc. Natl. Acad. Sci. U.S.A.95258–263. 10.1073/pnas.95.1.258
43
HagerlingR.HoppeE.DierkesC.StehlingM.MakinenT.ButzS.et al (2018). Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds.EMBO J.37e98271. 10.15252/embj.201798271
44
HagerlingR.PollmannC.AndreasM.SchmidtC.NurmiH.AdamsR. H.et al (2013). A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.EMBO J.32629–644. 10.1038/emboj.2012.340
45
HamanakaT.BillA.IchinohasamaR.IshidaT. (1992). Aspects of the development of Schlemm’s canal.Exp. Eye Res.55479–488.
46
HayasakaH.TaniguchiK.FukaiS.MiyasakaM. (2010). Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking.Cancer Sci.1012302–2308. 10.1111/j.1349-7006.2010.01687.x
47
HerrnbergerL.EbnerK.JunglasB.TammE. R. (2012). The role of plasmalemma vesicle-associated protein (PLVAP) in endothelial cells of Schlemm’s canal and ocular capillaries.Exp. Eye Res.10527–33. 10.1016/j.exer.2012.09.011
48
HerzogB. H.FuJ.WilsonS. J.HessP. R.SenA.McDanielJ. M.et al (2013). Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.Nature502105–109. 10.1038/nature12501
49
HerzogY.KalcheimC.KahaneN.ReshefR.NeufeldG. (2001). Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins.Mech. Dev.109115–119. 10.1016/s0925-4773(01)00518-4
50
HirashimaM.LuY.ByersL.RossantJ. (2003). Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta.Proc. Natl. Acad. Sci. U.S.A.10015637–15642. 10.1073/pnas.2635424100
51
HitchcockJ. R.CookC. N.BobatS.RossE. A.Flores-LangaricaA.LoweK. L.et al (2015). Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.J. Clin. Invest.1254429–4446. 10.1172/JCI79070
52
HongY. K.HarveyN.NohY. H.SchachtV.HirakawaS.DetmarM.et al (2002). Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.Dev Dyn.225351–357. 10.1002/dvdy.10163
53
HuangX. Z.WuJ. F.FerrandoR.LeeJ. H.WangY. L.FareseR. V.et al (2000). Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1.Mol. Cell Biol.205208–5215. 10.1128/mcb.20.14.5208-5215.2000
54
JaffeE. A.HoyerL. W.NachmanR. L. (1973). Synthesis of antihemophilic factor antigen by cultured human endothelial cells.J. Clin. Invest.522757–2764. 10.1172/jci107471
55
JanardhanH. P.TrivediC. M. (2019). Establishment and maintenance of blood-lymph separation.Cell Mol. Life Sci.761865–1876. 10.1007/s00018-019-03042-3
56
JungE.GardnerD.ChoiD.ParkE.Jin SeongY.YangS.et al (2017). Development and characterization of a novel Prox1-EGFP lymphatic and Schlemm’s canal reporter rat.Sci. Rep.75577. 10.1038/s41598-017-06031-3
57
KaipainenA.KorhonenJ.MustonenT.van HinsberghV. W.FangG. H.DumontD.et al (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.Proc. Natl. Acad. Sci. U.S.A.923566–3570. 10.1073/pnas.92.8.3566
58
KarkkainenM. J.HaikoP.SainioK.PartanenJ.TaipaleJ.PetrovaT. V.et al (2004). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.Nat. Immunol.574–80. 10.1038/ni1013
59
KarpinichN. O.CaronK. M. (2014). Schlemm’s canal, more than meets the eye, lymphatics in disguise.J. Clin Invest.1243701–3703. 10.1172/JCI77507
60
KatoT.ItoY.HosonoK.SuzukiT.TamakiH.MinaminoT.et al (2011). Vascular endothelial growth factor receptor-1 signaling promotes liver repair through restoration of liver microvasculature after acetaminophen hepatotoxicity.Toxicol. Sci.120218–229. 10.1093/toxsci/kfq366
61
Kenig-KozlovskyY.ScottR. P.OnayT.CarotaI. A.ThomsonB. R.GilH. J.et al (2018). Ascending vasa recta are angiopoietin/Tie2-dependent lymphatic-like vessels.J. Am. Soc. Nephrol.291097–1107. 10.1681/ASN.2017090962
62
KimJ.ParkD. Y.BaeH.ParkD. Y.KimD.LeeC. K.et al (2017). Impaired angiopoietin/Tie2 signaling compromises Schlemm’s canal integrity and induces glaucoma.J. Clin. Invest.1273877–3896. 10.1172/JCI94668
63
KizhatilK.RyanM.MarchantJ. K.HenrichS.JohnS. W. (2014). Schlemm’s canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process.PLoS Biol.12:e1001912. 10.1371/journal.pbio.1001912
64
KlotzL.NormanS.VieiraJ. M.MastersM.RohlingM.DubeK. N.et al (2015). Cardiac lymphatics are heterogeneous in origin and respond to injury.Nature52262–67. 10.1038/nature14483
65
KriehuberE.Breiteneder-GeleffS.GroegerM.SoleimanA.SchoppmannS. F.StinglG.et al (2001). Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.J. Exp. Med.194797–808. 10.1084/jem.194.6.797
66
LacorreD. A.BaekkevoldE. S.GarridoI.BrandtzaegP.HaraldsenG.AmalricF.et al (2004). Plasticity of endothelial cells, rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment.Blood1034164–4172. 10.1182/blood-2003-10-3537
67
LalorP. F.LaiW. K.CurbishleyS. M.ShettyS.AdamsD. H. (2006). Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.World J. Gastroenterol.125429–5439.
68
LampugnaniM. G.ResnatiM.RaiteriM.PigottR.PisacaneA.HouenG.et al (1992). A novel endothelial-specific membrane protein is a marker of cell-cell contacts.J. Cell Biol.1181511–1522. 10.1083/jcb.118.6.1511
69
LeeH. W.QinY. X.KimY. M.ParkE. Y.HwangJ. S.HuoG. H.et al (2011). Expression of lymphatic endothelium-specific hyaluronan receptor LYVE-1 in the developing mouse kidney.Cell Tissue Res.343429–444. 10.1007/s00441-010-1098-x
70
LeeM.KiefelH.LaJevicM. D.MacauleyM. S.KawashimaH.O’HaraE.et al (2014). Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing.Nat. Immunol.15982–995. 10.1038/ni.2983
71
LiM.SchwerbrockN. M.LenhartP. M.Fritz-SixK. L.KadmielM.ChristineK. S.et al (2013). Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta.J. Clin. Invest.1232408–2420. 10.1172/JCI67039
72
LiaoS.RuddleN. H. (2006). Synchrony of high endothelial venules and lymphatic vessels revealed by immunization.J. Immunol.1773369–3379. 10.4049/jimmunol.177.5.3369
73
LutterS.MakinenT. (2014). Regulation of lymphatic vasculature by extracellular matrix.Adv. Anat. Embryol. Cell Biol.21455–65. 10.1007/978-3-7091-1646-3_5
74
LyallF. (2002). The human placental bed revisited.Placenta23555–562. 10.1053/plac.2002.0850
75
MaW.OliverG. (2017). Lymphatic endothelial cell plasticity in development and disease.Physiology32444–452. 10.1152/physiol.00015.2017
76
MacParlandS. A.LiuJ. C.MaX. Z.InnesB. T.BartczakA. M.GageB. K.et al (2018). Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations.Nat. Commun.94383. 10.1038/s41467-018-06318-7
77
MahadevanA.WelshI. C.SivakumarA.GludishD. W.ShilvockA. R.NodenD. M.et al (2014). The left-right Pitx2 pathway drives organ-specific arterial and lymphatic development in the intestine.Dev. Cell31690–706. 10.1016/j.devcel.2014.11.002
78
Martinez-CorralI.UlvmarM. H.StanczukL.TatinF.KizhatilK.JohnS. W.et al (2015). Nonvenous origin of dermal lymphatic vasculature.Circ. Res.1161649–1654. 10.1161/CIRCRESAHA.116.306170
79
MatsuiT.Kanai-AzumaM.HaraK.MatobaS.HiramatsuR.KawakamiH.et al (2006). Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice.J. Cell Sci.119(Pt 17), 3513–3526. 10.1242/jcs.03081
80
MazurekR.DaveJ. M.ChandranR. R.MisraA.SheikhA. Q.GreifD. M. (2017). Vascular cells in blood vessel wall development and disease.Adv. Pharmacol.78323–350. 10.1016/bs.apha.2016.08.001
81
MimcheP. N.LeeC. M.MimcheS. M.ThapaM.GrakouiA.HenkemeyerM.et al (2018). EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells.Sci. Rep.82532. 10.1038/s41598-018-20926-9
82
MollW.WallenburgH. C.KastendieckE.VoslarM. (1978). The flow resistance of the spiral artery and the related intervillous space in the rhesus monkey placenta.Pflugers Arch.377225–228. 10.1007/bf00584276
83
Mouta CarreiraC.NasserS. M.di TomasoE.PaderaT. P.BoucherY.TomarevS. I.et al (2001). LYVE-1 is not restricted to the lymph vessels, expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.Cancer Res.618079–8084.
84
MuthuchamyM.GashevA.BoswellN.DawsonN.ZawiejaD. (2003). Molecular and functional analyses of the contractile apparatus in lymphatic muscle.FASEB J.17920–922. 10.1096/fj.02-0626fje
85
NagayaN.MoriH.MurakamiS.KangawaK.KitamuraS. (2005). Adrenomedullin, angiogenesis and gene therapy.Am. J. Physiol. Regul. Integr. Comp. Physiol.288R1432–R1437.
86
OliverG. (2004). Lymphatic vasculature development.Nat. Rev. Immunol.435–45. 10.1038/nri1258
87
PaderaT. P.MeijerE. F.MunnL. L. (2016). The lymphatic system in disease processes and cancer progression.Annu. Rev. Biomed. Eng.18125–158. 10.1146/annurev-bioeng-112315-031200
88
PalloneT. L.TurnerM. R.EdwardsA.JamisonR. L. (2003). Countercurrent exchange in the renal medulla.Am. J. Physiol. Regul. Integr. Comp. Physiol.284R1153–R1175.
89
PannabeckerT. L.DantzlerW. H. (2006). Three-dimensional architecture of inner medullary vasa recta.Am. J. Physiol. Renal, Physiol.290F1355–F1366.
90
ParkD. Y.LeeJ.ParkI.ChoiD.LeeS.SongS.et al (2014). Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity.J. Clin. Invest.1243960–3974. 10.1172/JCI75392
91
PawlakJ. B.BalintL.LimL.MaW.DavisR. B.BenyoZ.et al (2019). Lymphatic mimicry in maternal endothelial cells promotes placental spiral artery remodeling.J. Clin. Invest.1294912–4921. 10.1172/JCI120446
92
PennisiD.GardnerJ.ChambersD.HoskingB.PetersJ.MuscatG.et al (2000). Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice.Nat. Genet.24434–437. 10.1038/74301
93
PerkumasK. M.StamerW. D. (2012). Protein markers and differentiation in culture for Schlemm’s canal endothelial cells.Exp. Eye Res.9682–87. 10.1016/j.exer.2011.12.017
94
PetrovaT. V.KohG. Y. (2018). Organ-specific lymphatic vasculature. From development to pathophysiology.J. Exp. Med.21535–49. 10.1084/jem.20171868
95
PetrovaT. V.MakinenT.MakelaT. P.SaarelaJ.VirtanenI.FerrellR. E.et al (2002). Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.EMBO J.214593–4599. 10.1093/emboj/cdf470
96
PfeifferF.KumarV.ButzS.VestweberD.ImhofB. A.SteinJ. V.et al (2008). Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node.Eur. J. Immunol.382142–2155. 10.1002/eji.200838140
97
PijnenborgR.VercruysseL.HanssensM. (2006). The uterine spiral arteries in human pregnancy, facts and controversies.Placenta27939–958. 10.1016/j.placenta.2005.12.006
98
PodgrabinskaS.BraunP.VelascoP.KloosB.PepperM. S.SkobeM. (2002). Molecular characterization of lymphatic endothelial cells.Proc. Natl. Acad. Sci. U.S.A.9916069–16074.
99
PoissonJ.LemoinneS.BoulangerC.DurandF.MoreauR.VallaD.et al (2017). Liver sinusoidal endothelial cells, physiology and role in liver diseases.J. Hepatol.66212–227. 10.1016/j.jhep.2016.07.009
100
PotenteM.MakinenT. (2017). Vascular heterogeneity and specialization in development and disease.Nat. Rev. Mol. Cell Biol.18477–494. 10.1038/nrm.2017.36
101
PupilliC.RomagnaniP.LasagniL.BelliniF.MiscigliaN.EmotoN.et al (1997). Localization of endothelin-converting enzyme-1 in human kidney.Am. J. Physiol.273F749–F756. 10.1152/ajprenal.1997.273.5.F749
102
RaiA.CrossJ. C. (2014). Development of the hemochorial maternal vascular spaces in the placenta through endothelial and vasculogenic mimicry.Dev. Biol.387131–141. 10.1016/j.ydbio.2014.01.015
103
RamosR. F.HoyingJ. B.WitteM. H.Daniel StamerW. (2007). Schlemm’s canal endothelia, lymphatic, or blood vasculature?J. Glaucoma16391–405. 10.1097/ijg.0b013e3180654ac6
104
RandolphG. J.IvanovS.ZinselmeyerB. H.ScallanJ. (2017). The lymphatic system, integral roles in immunity.Annu. Rev. Immunol.3531–52. 10.1146/annurev-immunol-041015-055354
105
RantakariP.AuvinenK.JappinenN.KapraaliM.ValtonenJ.KarikoskiM.et al (2015). The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes.Nat. Immunol.16386–396. 10.1038/ni.3101
106
RantakariP.JappinenN.LokkaE.MokkalaE.GerkeH.PeuhuE.et al (2016). Fetal liver endothelium regulates the seeding of tissue-resident macrophages.Nature538392–396. 10.1038/nature19814
107
Red-HorseK.RiveraJ.SchanzA.ZhouY.WinnV.KapidzicM.et al (2006). Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation.J. Clin. Invest.1162643–2652. 10.1172/jci27306
108
RobsonA.HarrisL. K.InnesB. A.LashG. E.AljunaidyM. M.AplinJ. D.et al (2012). Uterine natural killer cells initiate spiral artery remodeling in human pregnancy.FASEB J.264876–4885. 10.1096/fj.12-210310
109
RussellP. S.HongJ.WindsorJ. A.ItkinM.PhillipsR. J. A. (2019). Renal lymphatics, anatomy, physiology, and clinical implications.Front. Physiol.10:251. 10.3389/fphys.2019.00251
110
SamulowitzU.KuhnA.BrachtendorfG.NawrothR.BraunA.BankfalviA.et al (2002). Human endomucin, distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope.Am. J. Pathol.1601669–1681.
111
SatoT. N.TozawaY.DeutschU.Wolburg-BuchholzK.FujiwaraY.Gendron-MaguireM.et al (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.Nature37670–74. 10.1038/376070a0
112
ScallanJ. P.ZawiejaS. D.Castorena-GonzalezJ. A.DavisM. J. (2016). Lymphatic pumping, mechanics, mechanisms and malfunction.J. Physiol.5945749–5768. 10.1113/JP272088
113
SchwartzM. M.KarnovskyM. J.VehkatachalamM. A. (1976). Ultrastructural differences between rat inner medullary descending and ascending vasa recta.Lab. Invest.35161–170.
114
SeoS.FujitaH.NakanoA.KangM.DuarteA.KumeT. (2006). The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.Dev. Biol.294458–470. 10.1016/j.ydbio.2006.03.035
115
ShalabyF.RossantJ.YamaguchiT. P.GertsensteinM.WuX. F.BreitmanM. L.et al (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.Nature37662–66. 10.1038/376062a0
116
ShenB.ShangZ.WangB.ZhangL.ZhouF.LiT.et al (2014). Genetic dissection of tie pathway in mouse lymphatic maturation and valve development.Arterioscler. Thromb. Vasc. Biol.341221–1230. 10.1161/ATVBAHA.113.302923
117
SrinivasanR. S.DillardM. E.LagutinO. V.LinF. J.TsaiS.TsaiM. J.et al (2007). Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature.Genes Dev.212422–2432. 10.1101/gad.1588407
118
StanR. V.GhitescuL.JacobsonB. S.PaladeG. E. (1999a). Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein.J. Cell Biol.1451189–1198. 10.1083/jcb.145.6.1189
119
StanR. V.KubitzaM.PaladeG. E. (1999b). PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia.Proc. Natl. Acad. Sci. U.SA.9613203–13207. 10.1073/pnas.96.23.13203
120
StanczukL.Martinez-CorralI.UlvmarM. H.ZhangY.LavinaB.FruttigerM.et al (2015). cKit lineage hemogenic endothelium-derived cells contribute to mesenteric lymphatic vessels.Cell Rep.101708–1721. 10.1016/j.celrep.2015.02.026
121
SweeneyM.JonesC. J.GreenwoodS. L.BakerP. N.TaggartM. J. (2006). Ultrastructural features of smooth muscle and endothelial cells of isolated isobaric human placental and maternal arteries.Placenta27635–647. 10.1016/j.placenta.2005.05.010
122
Takahashi-IwanagaH. (1991). The three-dimensional cytoarchitecture of the interstitial tissue in the rat kidney.Cell Tissue Res.264269–281. 10.1007/bf00313964
123
TammE. R. (2009). The trabecular meshwork outflow pathways, structural and functional aspects.Exp. Eye Res.88648–655. 10.1016/j.exer.2009.02.007
124
ThomsonB. R.HeinenS.JeanssonM.GhoshA. K.FatimaA.SungH. K.et al (2014). A lymphatic defect causes ocular hypertension and glaucoma in mice.J. Clin. Invest.1244320–4324. 10.1172/JCI77162
125
TruongT. N.LiH.HongY. K.ChenL. (2014). Novel characterization and live imaging of Schlemm’s canal expressing Prox-1.PLoS One9:e98245. 10.1371/journal.pone.0098245
126
UlvmarM. H.MakinenT. (2016). Heterogeneity in the lymphatic vascular system and its origin.Cardiovasc. Res.111310–321. 10.1093/cvr/cvw175
127
van MourikJ. A.LeeksmaO. C.ReindersJ. H.de GrootP. G.Zandbergen-SpaargarenJ. (1985). Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa.J. Biol. Chem.26011300–11306.
128
VrochidesD.PapanikolaouV.PertoftH.AntoniadesA. A.HeldinP. (1996). Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration.Hepatology231650–1655. 10.1002/hep.510230648
129
WalterT. J.CastA. E.HuppertK. A.HuppertS. S. (2014). Epithelial VEGF signaling is required in the mouse liver for proper sinusoid endothelial cell identity and hepatocyte zonation in vivo.Am. J. Physiol. Gastrointest. Liver Physiol.306G849–G862. 10.1152/ajpgi.00426.2013
130
WangH. U.ChenZ. F.AndersonD. J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.Cell93741–753. 10.1016/s0092-8674(00)81436-1
131
WeberM.HauschildR.SchwarzJ.MoussionC.de VriesI.LeglerD. F.et al (2013). Interstitial dendritic cell guidance by haptotactic chemokine gradients.Science339328–332. 10.1126/science.1228456
132
WhitleyG. S.CartwrightJ. E. (2010). Cellular and molecular regulation of spiral artery remodelling, lessons from the cardiovascular field.Placenta31465–474. 10.1016/j.placenta.2010.03.002
133
WigleJ. T.OliverG. (1999). Prox1 function is required for the development of the murine lymphatic system.Cell98769–778. 10.1016/s0092-8674(00)81511-1
134
WiltingJ.ArefY.HuangR.TomarevS. I.SchweigererL.ChristB.et al (2006). Dual origin of avian lymphatics.Dev. Biol.292165–173. 10.1016/j.ydbio.2005.12.043
135
WisseE. (1972). An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells.J. Ultrastruct. Res.38528–562. 10.1016/0022-5320(72)90089-5
136
WongB. W.ZecchinA.Garcia-CaballeroM.CarmelietP. (2018). Emerging concepts in organ-specific lymphatic vessels and metabolic regulation of lymphatic development.Dev. Cell.45289–301. 10.1016/j.devcel.2018.03.021
137
WrobelT.DziegielP.MazurG.ZabelM.KuliczkowskiK.SzubaA. (2005). LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes.Lymphology38107–110.
138
YamamotoK.de WaardV.FearnsC.LoskutoffD. J. (1998). Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo.Blood922791–2801. 10.1182/blood.v92.8.2791.420k24_2791_2801
139
YamaneA.SeetharamL.YamaguchiS.GotohN.TakahashiT.NeufeldG.et al (1994). A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).Oncogene92683–2690.
140
YangY.Garcia-VerdugoJ. M.Soriano-NavarroM.SrinivasanR. S.ScallanJ. P.SinghM. K.et al (2012). Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos.Blood1202340–2348. 10.1182/blood-2012-05-428607
141
YetS. F.McA’NultyM. M.FoltaS. C.YenH. W.YoshizumiM.HsiehC. M.et al (1998). Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains.J. Biol. Chem.2731026–1031. 10.1074/jbc.273.2.1026
142
YokomoriH.OdaM.KanekoF.KawachiS.TanabeM.YoshimuraK.et al (2010). Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver–re-evaluations of microlymphatic abnormalities.BMC Gastroenterol.10:131. 10.1186/1471-230X-10-131
143
YoshidaR.NagiraM.KitauraM.ImagawaN.ImaiT.YoshieO. (1998). Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.J. Biol. Chem.2737118–7122. 10.1074/jbc.273.12.7118
144
YouL. R.LinF. J.LeeC. T.DeMayoF. J.TsaiM. J.TsaiS. Y. (2005). Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity.Nature43598–104. 10.1038/nature03511
145
YoungM. D.MitchellT. J.Vieira BragaF. A.TranG. B. M.StewartB. J.FerdinandJ. R.et al (2018). Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors.Science361594–599. 10.1126/science.aat1699
146
YuanL.MoyonD.PardanaudL.BreantC.KarkkainenM. J.AlitaloK.et al (2002). Abnormal lymphatic vessel development in neuropilin 2 mutant mice.Development1294797–4806.
147
ZhangJ.DongH.WangB.ZhuS.CroyB. A. (2008). Dynamic changes occur in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice.Biol. Reprod.79450–458. 10.1095/biolreprod.108.067975
Summary
Keywords
lymphatic, endothelium, hybrid vessel, liver sinusoid, high endothelial venule
Citation
Pawlak JB and Caron KM (2020) Lymphatic Programing and Specialization in Hybrid Vessels. Front. Physiol. 11:114. doi: 10.3389/fphys.2020.00114
Received
20 November 2019
Accepted
31 January 2020
Published
20 February 2020
Volume
11 - 2020
Edited by
Vincenza Cifarelli, Washington University in St. Louis, United States
Reviewed by
Young-Kwon Hong, University of Southern California Keck School of Medicine, United States; Nancy H. Ruddle, Yale University School of Medicine, United States
Updates
Copyright
© 2020 Pawlak and Caron.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kathleen M. Caron, kathleen_caron@med.unc.edu
This article was submitted to Lipid and Fatty Acid Research, a section of the journal Frontiers in Physiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.